We demonstrated that HOXC10 promoted HCC metastasis by upregulating 3-phosphoinositide-dependent protein kinase 1 (PDPK1) and vasodilator-stimulated phosphoprotein (VASP). Here, HOXC10 is linked to hepatocellular carcinoma.